Skip to content

Evaluation of the use of Lactobacilli for gum treatment in patients with Diabetes

Effect of Probiotic Therapy (Lactobacillus reuteri) in the treatment of chronic periodontitis associated with Diabetes Mellitus. Clinical, controlled and randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8t4qqx
Enrollment
Unknown
Registered
2020-10-08
Start date
2020-08-24
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial infections and mycoses

Interventions

This is a two-arm, double-blind, randomized controlled clinical trial. Procedure: periodontal treatment through mechanical debridement, with scaling and subgingival smoothing. This procedure will be p
G07.203.300.456.500

Sponsors

Universidade Estadual Paulista Júlio de Mesquita Filho
Lead Sponsor
Universidade Estadual Paulista Júlio de Mesquita Filho
Collaborator

Eligibility

Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Individuals over 35 years old; patients with type 2 diabetes mellitus; carriers of generalized chronic periodontitis; present at least 16 teeth; agree to participate in the study and sign the informed consent form for participation in the research

Exclusion criteria

Exclusion criteria: Patients with cardiovascular disease, cancer, gastrointestinal disorders, skin diseases, pregnancy, lactation, smoking, arthritis, lupus; have undergone periodontal treatment in the last 12 months; have made use of antioxidant, anti-inflammatory, or antibiotic supplements within the previous 3 months; have changed the blood glucose control medication in the last 3 months; present dental elements with pulp or periapical inflammation; have any other diseases of inflammatory origin

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: It was expected to find a greater reduction in the pocket depth measured, the primary variable of the study, in the group with adjuvant therapy with the probiotic, verified through clinical periodontal examination. It was also expected to assess the response of inflammatory mediators and the lipid and microbiological profile to the applied intervention.;Outcome found 1: Through the clinical examination, there was a reduction in probing depth in both groups, a reduction in the amount of periodontopathogenic bacteria in periodontal pockets and a change in the lipid profile of the probiotic group.

Secondary

MeasureTime frame
Secondary outcomes were not expected.

Countries

Brazil

Contacts

Public ContactMaria Aparecida Jardini

Universidade Estadual Paulista Júlio de Mesquita Filho

maria.jardini@unesp.br+55-12-39479046

Outcome results

None listed

Source: REBEC (via WHO ICTRP)